NDC codes

FDA NDC Directory
Product NDC (as listed)59572-720Labeler and product segments. Claims need a package NDC.
Product NDC at billing width59572-0720Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
59572-720-1259572072012120 CAPSULE in 1 BOTTLE, PLASTIC (59572-720-12)Marketed from Aug 16, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Inrebic
Generic name (nonproprietary)
fedratinib hydrochloride
Active ingredients
Fedratinib hydrochloride — 100 mg/1
Dosage form
Capsule
Route
Oral
Labeler
Celgene CorporationNDC labeler code 59572
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 212327
Marketing start
Listing expires
Identifiers
Product ID 59572-720_c328016b-fc3e-4d6f-99b3-8d2c13b362f3SPL ID c328016b-fc3e-4d6f-99b3-8d2c13b362f3SPL set ID f0f55a2a-4e0c-4cba-8571-03e1424486d7RxCUI 2197495, 2197501UNII UH9J2HBQWJ

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459572072012 followed by a unit qualifier and the quantity

Package 59572-0720-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

INREBIC ® is indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF). INREBIC is a kinase inhibitor indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis (MF) ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59572-720

What is NDC 59572-720?
59572-720 is the product NDC for Inrebic (fedratinib hydrochloride), Fedratinib hydrochloride 100 mg/1 capsule, listed with the FDA by Celgene Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Inrebic (Fedratinib Hydrochloride).
What is the active ingredient?
Fedratinib hydrochloride.
Who is the labeler?
Celgene Corporation, NDC labeler code 59572. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Inrebic?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in